|
TRAK2 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.35769995246449E-09 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.01960000001389E-06 |
| Normal-vs-Stage2 |
7.378600E-03 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
1.845980E-02 |
| Stage1-vs-Stage2 |
4.686000E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
1.563410E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
5.068000E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.03960000397541E-08 |
| Normal-vs-AfricanAmerican |
5.040100E-02 |
| Normal-vs-Asian |
1.402760E-01 |
| Caucasian-vs-AfricanAmerican |
4.675600E-02 |
| Caucasian-vs-Asian |
4.735000E-01 |
| AfricanAmerican-vs-Asian |
3.453000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.13790000000281E-05 |
| Normal-vs-Female |
1.65384999999407E-05 |
| Male-vs-Female |
3.401000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.537700E-03 |
| Normal-vs-Extreme_Weight |
2.565300E-04 |
| Normal-vs-Obese |
1.801330E-03 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
7.489400E-01 |
| Normal_Weight-vs-Obese |
8.214600E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
9.303600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
2.258200E-01 |
| Normal-vs-Grade 3 |
1.240980E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
4.386000E-01 |
| Grade 2-vs-Grade 4 |
2.258200E-01 |
| Grade 3-vs-Grade 4 |
1.240980E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.86619999956272E-07 |
| Normal-vs-N1 |
4.903800E-02 |
| N0-vs-N1 |
5.073000E-01 |
|
|
